The Nasdaq Stock Market ended the session with Moderna jumping 16.35% to $127.03 on Friday, following yesterday’s upward trend. The Nasdaq Stock Market jumped 0.92% to $12,205.80, after three successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Moderna today’s close was $127.03, 2.39% below its 52-week high of $130.06.
Moderna’s sales growth is 1425.2% for the current quarter and 9666.5% for the next. The company’s growth estimates for the present quarter is a negative 48.6% and positive 437.1% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $127.03 at 18:17 EST, below its 52-week high of $130.06 and way above its 52-week low of $17.68.
Moderna’s worth is way above its 50-day moving average of $79.01 and way higher than its 200-day moving average of $70.45.
According to Bloomberg Quint on Mon Nov 23, “Moderna Chief Sells More Shares Ahead of Urgent Vaccine Filing.”
According to Bloomberg Quint on Wed Nov 25, “Moderna Soars to Record Ahead of Final Covid Vaccine Analysis.”